HEDIS® Results
Medicaid HEDIS® Annual Rates.
Medicaid HEDIS® Annual Rates.
Senior Whole Health’s scores for the past two years are below. You can see how Senior Whole Health performs compared to our target goal.
|
Measure |
2023 Rate |
2023 Goal |
2024 Rate |
2024 Goal |
|
Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA) |
NA |
64.90% |
100.00% |
66.15% |
|
Annual Dental Visits (ADV) Total |
NA |
54.60% |
|
|
|
Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment |
83.33% |
46.74% |
54.17% |
48.16% |
|
Appropriate Testing for Pharyngitis (CWP) |
NA |
77.56% |
40.00% |
85.11% |
|
Appropriate Treatment for Upper Respiratory Infection (URI) Total |
NA |
93.08% |
75.00% |
91.27% |
|
Asthma Medication Ratio (AMR) Total |
NA |
69.41% |
NA |
70.56% |
|
Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB) |
NA |
66.19% |
33.33% |
67.03% |
|
Blood Pressure Control (<140/90) for Patients With Diabetes (BPD) |
58.62% |
68.61% |
65.32% |
71.78% |
|
Breast Cancer Screening (BCS) |
64.80% |
55.25% |
|
|
|
Breast Cancer Screening (BCS-E) |
64.80% |
54.94% |
65.84% |
56.66% |
|
Cervical Cancer Screening (CCS) |
NA |
59.85% |
NA |
60.10% |
|
Childhood Immunization Status (CIS) Combination #10 |
NA |
35.04% |
NA |
31.32% |
|
Chlamydia Screening in Women (CHL) Total |
NA |
61.07% |
NA |
61.46% |
|
Controlling High Blood Pressure (CBP) |
49.15% |
65.45% |
59.28% |
67.40% |
|
Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD) |
NA |
80.86% |
NA |
83.51% |
|
Eye Exam for Patients With Diabetes (EED) |
70.11% |
56.20% |
69.94% |
57.09% |
|
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total |
NA |
27.73% |
NA |
27.62% |
|
Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total |
NA |
46.35% |
0.00% |
44.33% |
|
Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total |
NA |
41.03% |
0.00% |
42.86% |
|
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total |
NA |
37.31% |
NA |
37.64% |
|
Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase |
NA |
57.90% |
NA |
56.86% |
|
Follow-Up for Children Prescribed ADHD Medication (ADD-E) Continuation and Maintenance Phase |
|
|
NA |
56.83% |
|
Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%) |
58.05% |
55.72% |
71.68% |
59.64% |
|
Immunizations for Adolescents (IMA) Combination #2 |
NA |
38.93% |
NA |
38.69% |
|
Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total |
NA |
16.94% |
0.00% |
16.78% |
|
Kidney Health Evaluation for Patients with Diabetes (KED) |
43.15% |
38.80% |
43.24% |
42.10% |
|
Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total |
NA |
39.01% |
NA |
41.92% |
|
Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) Blood Glucose and Cholesterol Testing Total |
|
|
NA |
41.41% |
|
Pharmacotherapy for Opioid Use Disorder (POD) Total |
NA |
31.93% |
NA |
29.01% |
|
Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids |
NA |
75.79% |
83.33% |
74.78% |
|
Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator |
NA |
86.96% |
66.67% |
86.54% |
|
Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years |
NA |
≤ 92.72% |
NA |
≤ 91.24% |
|
Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care |
NA |
86.86% |
NA |
86.89% |
|
Prenatal and Postpartum Care (PPC) Postpartum Care |
NA |
80.78% |
NA |
82.48% |
|
Prenatal Immunization Status (PRS) Combination Rate |
NA |
25.81% |
|
|
|
Prenatal Immunization Status (PRS-E) Combination Rate |
NA |
25.81% |
NA |
24.92% |
|
Risk of Continued Opioid Use (COU) 31-Day Total |
16.39% |
≤ 2.45% |
5.36% |
≤ 2.79% |
|
Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total |
NA |
81.64% |
92.31% |
83.00% |
|
Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total |
NA |
73.63% |
83.33% |
74.07% |
|
Statin Therapy for Patients with Diabetes (SPD) Received Statin Therapy |
85.44% |
67.07% |
74.34% |
67.01% |
|
Statin Therapy for Patients with Diabetes (SPD) Statin Adherence 80% |
85.23% |
70.37% |
79.76% |
70.91% |
|
Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total |
NA |
63.89% |
NA |
64.10% |
|
Use of Imaging Studies for Low Back Pain (LBP) |
NA |
75.44% |
73.68% |
72.74% |
|
Use of Opioids at High Dosage (HDO) |
NA |
≤ 2.19% |
0.00% |
≤ 2.14% |
|
Use of Opioids from Multiple Providers (UOP) Multiple Prescribers and Multiple Pharmacies |
0% |
≤ 0.87% |
0.00% |
≤ 1.22% |
|
Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile |
NA |
83.21% |
NA |
86.20% |